[1] Stein I F, Leventhal L M. Amenorrhea associated with bilateral polycystic ovaries[J]. Am J Obstet Gynecol, 1935,29:181-191. [2] Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS):the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J]. Fertil Steril, 2012, 97(1):28-38. [3] The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J]. Hum Reprod, 2004, 19(1):41-47. [4] Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome[J]. Fertil Steril, 2016,106(1):6-15. [5] 中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志,2018,53(1):2-6. [6] 王虎生, 阮祥燕, 李雪, 等. 抗苗勒管激素与抑制素B对多囊卵巢综合征的临床预测价值[J].首都医科大学学报, 2017,38(4):492-497. [7] Dursun F, Güven A, Yıldız M. Assessment of anti-Müllerian hormone level in management of adolescents with polycystic ovary syndrome[J]. J Clin Res Pediatr Endocrinol, 2016,8(1):55-60. [8] Pawelczak M, Kenigsberg L, Milla S, et al. Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome:relationship toultrasound features[J]. J Pediatr Endocrinol Metab, 2012,25(9-10):983-989. [9] Cassar S, Teede H J, Moran L J, et al. Polycystic ovary syndrome and anti-Müllerian hormone:role of insulin resistance, androgens, obesity and gonadotrophins[J]. Clin Endocrinol (Oxf), 2014, 81(6):899-906. [10] 付志红, 邢福棋. 活性氧与女性生殖[J]. 国外医学计划生育分册, 2005,24(3):107-109. [11] Oyawoye O, Abdel Gadir A, Garner A, et al. Antioxidants and reactive oxygen species in follicular fluid of wowlen undergoing IVF:relationship to outcome[J]. Hum Reprod, 2003, 18(ii)l2270-2274. [12] Carbone M C, Tatone C, Delle Monache S, et al. Antioxidant enzymatic defences in human folicular fluid:characterization and age-dependent changes[J]. Mol Hum Reprod, 2003, 9(11):639-643. [13] Török A, Belagyi J, Török B, et al. Scaventger capacity of follicular fluid, decidua and culture medium with regard to assisted reproduction:an in vitro study using electron paramagnetic resonance spectroscopy[J].Gynecol Obstet Invest, 2003, 55(3):178-182. [14] Seleem A K, El Refaeey A A, Shaalan D, et al. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection[J]. J Assist Reprod Genet,2014,31(4):499-504. [15] Turan V, Sezer E D, Zeybek B, et al. Infertility and the presence of insulin resistance are associated with increased oxidative stress in young, non-obese Turkish women with polycystic ovary syndrome[J]. J Pediatr Adolesc Gynecol,2015,28(2):119-123. [16] Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS):a systematic review and meta-analysis[J]. Human Reprod Update, 2013,19(3):268-288. [17] Sugino N, Takiguchi S, Kashida S, et al. Superoxide dismutase expression in the human corpus luteum during the menstrual cycle and in early pregnancy[J]. Mol Hum Reprod, 2000, 6(1):19-25. [18] 梅玲蔚, 熊正爱.氧化应激与多囊卵巢综合征的研究进展[J]. 广东医学, 2014, 35(8):1282-1284. [19] Iliodromiti S, Kelsey TW, Anderson RA, et al.Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data[J].J Clin Endocrinol Metab,2013, 98(8):3332-3340. [20] Özer A, Bakacak M, Kıran H, et al. Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome[J].Ginekol Pol,2016,87(11):733-738. [21] Enli Y, Fenkci S M, Fenkci V, et al. Serum fetuin-a levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome[J].Gynecol Endocrinol,2013,29(12):1036-1039. |